Cocrystal Pharma (COCP) Projected to Post Earnings on Monday

Cocrystal Pharma (NASDAQ:COCP) is expected to release its earnings data before the market opens on Monday, May 12th. Analysts expect Cocrystal Pharma to post earnings of ($0.52) per share for the quarter.

Cocrystal Pharma (NASDAQ:COCP) last released its quarterly earnings data on Thursday, March 27th. The company reported ($0.32) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.23. On average, analysts expect Cocrystal Pharma to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Cocrystal Pharma Stock Down 3.1 %

Shares of COCP opened at $1.52 on Friday. Cocrystal Pharma has a 52-week low of $1.12 and a 52-week high of $3.26. The stock has a fifty day simple moving average of $1.48 and a two-hundred day simple moving average of $1.84. The company has a market capitalization of $15.46 million, a PE ratio of -0.82 and a beta of 2.13.

Analyst Upgrades and Downgrades

Separately, HC Wainwright restated a “buy” rating and set a $7.00 price objective on shares of Cocrystal Pharma in a research report on Wednesday, January 22nd.

Cocrystal Pharma Company Profile

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.